There were four principal efficacy measures, all based on PRO instruments, variably used as primary or secondary tools to evaluate efficacy in the pivotal Phase 3 studies (Table 3).
Table 3 Summary of Pre-specified Outcome Measures - Pivotal Phase 3 Studies in Premenopausal Women